publication venue for Cardiovascular risk factors and lifetime risk estimation in HIV-infected patients under antiretroviral treatment in Spain.. 57-65. 2015 Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens.. 309-313. 2008
